Stock pick of the week: What makes Cadila Healthcare analysts top betBetter than expected sales and net profit growth, limited impact of US FDA due to its limited exposure, and among other things, have made i...
- Buy Cadila Healthcare, target Rs 444: Equirus Securities
Buy Cadila Healthcare Ltd. at a price target of Rs 444.0 .
- Buy Cadila Healthcare Ltd. target Rs 600 : Edelweiss Financial Services
Buy Cadila Healthcare Ltd. at a price target of Rs 600. Edelweiss says Cadila's US business growth will be best-in-class at 48 per cent wit...
Suffering from heartburn? Popping drugs may lead to 'silent' kidney damageA new study shows that people regularly taking drugs for heartburn may experience long-term damage.
Margin improvement will happen once new approvals come in: Pankaj Patel of Cadila HealthcareWe should expect significant approval coming in, in FY18 we expect 40 plus approvals may be happening now.
Common antacid may treat tuberculosis: StudyTuberculosis continues to be a global pandemic, second only to AIDS as the greatest single-agent killer in the world.
'One-fifth of stomach ailment patients can be given simpler cure'Aimed at bringing international standards to the care of patients suffering from functional bowel disease, the institute is hosting a three...
Sun Pharmaceuticals files ANDAs for 4 products in Q1 FY14Sun Pharmaceutical Industries filed Abbreviated New Drug Applications for 4 products & received 9 approvals from USFDA in Q1 this fiscal.
Sun Pharma gets USFDA approval for generic PrevacidSun Pharmaceutical Industries Ltd. received US FDA permission for its Abbreviated New Drug Applications (ANDA) for generic version of Preva...
Wockhardt gets USFDA approval for anti-ulcer drugDrug firm Wockhardt today said it has received approval from American health regulator to market Lansoprazole, a drug used in treatment of ...
- Dr Reddy's launches lansoprazole capsules in US market
The company has launched over-the-counter lansoprazole delayed-release capsules in the US market on May 18.
- Kids pop heartburn drugs
The number of young children on prescription drugs for heartburn and other digestive problems jumped about 56% in recent years.